Shanghai Pulmonary Hospital, Shanghai, China: Lung Neoplasms trials
The registry lists 57 Lung Neoplasms studies with Shanghai Pulmonary Hospital, Shanghai, China as lead sponsor. 38 are open to participants now and 0 have results posted.
Phase 2 26Phase 3 4No phase 27(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Application of Electromagnetic Navigation System in Pulmonary Nodule LocalizationNot yet recruitingNCT07595120Not applicable
- A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational StudyNot yet recruitingNCT07375979
- Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter StudyRecruitingNCT07243873
- Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride BupivacaineRecruitingNCT07134660Not applicable
- A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer TherapyNot yet recruitingNCT07101627Phase 2
- The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe SurgeryEnrolling by invitationNCT07060625
- Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer PatientsRecruitingNCT06987734Phase 2
- Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical StudyNot yet recruitingNCT06946836Phase 2
- Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLCNot yet recruitingNCT06837948Phase 2
- A Study on the Efficacy of Atezolizumab Combined with ChemotherapyRecruitingNCT06780826
- Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung CancerRecruitingNCT06758700Phase 2
- Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expressionRecruitingNCT06749860Phase 2
- Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06644313Phase 2
- Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical TrialNot yet recruitingNCT06620822Phase 2
- The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer PatietnsNot yet recruitingNCT06592430
- Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung CancerNot yet recruitingNCT06591910
- A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLCNot yet recruitingNCT06585644Phase 2
- Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung CancerNot yet recruitingNCT06463171Phase 2
- Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory TrialNot yet recruitingNCT06282536Phase 2
- Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 TrialRecruitingNCT06256237Phase 2
- Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world StudyRecruitingNCT06216782
- Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung CancerNot yet recruitingNCT06109402Phase 2
- Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung CancerRecruitingNCT05965024
- Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung CancerRecruitingNCT05925751
- Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung CancerRecruitingNCT05925738
- Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 TrialNot yet recruitingNCT05891080Phase 2
- Application of SERS Technology in Clinical Diagnosis and Prognosis of Lung Cancer ImmunotherapyNot yet recruitingNCT05885815
- Application of SERS Technology Based Intraoperative Navigation System in Lung CancerNot yet recruitingNCT05881057
- Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor EnvironmentRecruitingNCT05857800
- Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung CancerRecruitingNCT05766800Phase 2
- The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung CancerNot yet recruitingNCT05496166Phase 3
- Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical TrialRecruitingNCT05053802Phase 2
- Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)Not yet recruitingNCT04772287Phase 3
- Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II StudyRecruitingNCT04762030Phase 2
- Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung CancerRecruitingNCT04728724Phase 2
- Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung CancerNot yet recruitingNCT04676815
- Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung CancerRecruitingNCT04542369Phase 2
- VATS VS. Open Thoracic Surgery for Stage II - III Lung CancerRecruitingNCT04009915Phase 3
- Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung CancerWithdrawnNCT06895941
- Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and TreatmentStatus unknownNCT06086587
- Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung CancerStatus unknownNCT05425134
- Clinical Characteristics of Lung Cancer in ChinaStatus unknownNCT05423236
- Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyStatus unknownNCT04985201Phase 2
- a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung CancerStatus unknownNCT04790539Phase 2
- Application of Three-Dimensionally Printed Navigational Template in Lung BiopsyStatus unknownNCT04775901Not applicable
- Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyStatus unknownNCT04698941Phase 2
- Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer PatientsStatus unknownNCT04696939Phase 2
- Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung CancerActive, not recruitingNCT04685070Phase 2
- Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung CancerTerminatedNCT04422392Phase 2
- Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung CancerActive, not recruitingNCT04379739Phase 2
- Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLCStatus unknownNCT04372732
- Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 InhibitorsStatus unknownNCT04355806
- Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer PatientsStatus unknownNCT04203095
- Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene MutationStatus unknownNCT04137718
- NGS Combined With RNAseq on Tumor Immune Escape in NSCLCStatus unknownNCT03764917
- Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung CancerCompletedNCT03331588Phase 3
- Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility TrialCompletedNCT03325907Not applicable